-
Democrats, Trump hold final rallies before midterm elections
-
African players in Europe: Defender Hakimi's historic hat-trick
-
Japan urges US to enforce discipline after second Marine arrest
-
Struggling Slavia face Arsenal as grim record looms
-
'Remarkable' rookie Lendeborg scores 37 as Warriors beat Clippers
-
Vikings suffer first loss while Broncos edge Chiefs in NFL
-
ExxonMobil urged to re-think Papua New Guinea gas project
-
South Korea to double spending on AI and chips in 2027
-
Asian stocks mixed as tech sector struggles to rebound from selloff
-
On All Saints' Day, Philippine mountain town honours dead with fire
-
India's royals find new power in their past
-
Years on from fall of IS, French jihadists face justice in Iraq
-
Irish bookshops help meet UK demand for Sally Rooney novels
-
Point of Law favourite at Australia's 'race that stops a nation'
-
NFL Vikings suffer first loss while Broncos edge Chiefs
-
'Kid' Antonelli gets affectionate tributes from all quarters
-
Host of fresh faces in Australia white-ball squads to face England
-
Hamilton accuses Leclerc of wrecking Ferrari hopes
-
NFL linebacker Campbell to remain hospitalized overnight
-
Palo Alto Collaboration Company Opens Waitlist for Pana, a Personal AI That Builds Tools That Stay Yours
-
XCF Global Withdraws Reverse Stock Split Proposal; Reaffirms Growth Strategy and Shareholder Support
-
Gladstone Commercial Corporation Earnings Call and Webcast Information
-
cbdMD Completes Acquisition of the Operating Assets and Brands of Twinlab, including Twinlab, Reserveage and Metabolife Brands, Expanding Into Broader Wellness
-
Vicapsys Life Sciences Provides Shareholder Update on VICAPSYN(TM) Program Advancing Toward Phase 1 Human Clinical Trial, Vertically Integrated With the Company's Indian Health Service Strategy
-
Anthony, Linder & Cacomanolis Recognized in Chambers & Partners Spotlight Florida 2027 for Securities Law Excellence
-
Tectonic Metals Intersects 5.61 g/t Au Over 41.15 m, Including 12.94 g/t Au Over 13.72 m, Within 2.86 g/t Au Over 91.44 m, Strengthening Evidence for a Second Gold System at the Flat Gold Project
-
IRS Pushes Tax Deadlines to February 1, 2027 for Washington Wildfire Counties - Clear Start Tax Explains What the Postponement Does Not Pause
-
Optimistivity Unveils Refreshed Brand and Expanded Digital Product Range
-
GameSquare to Report Q3 2026 Financial Results on November 16, 2026
-
AsiaFIN Holdings Corp. to Host Q3 2026 Earnings Webcast from New York City
-
Predictiv AI Awarded Metrolinx Master Agreement for On-Demand Transit Software and Related Services
-
Electric Metals (USA) Limited Announces Results of Annual Meeting of Stockholders
-
iAsk.ai Surpasses One Billion Searches
-
International Battery Metals Announces Second Quarter Fiscal 2027 Financial Results Conference Call and Webcast
-
Electrovaya Ranks Fourth Among Canada's Enterprise - Industry Leaders in Deloitte's Technology Fast 50(TM) Program
-
BEING rather than HAVING. A fascinating, practical STORY.
-
Hospital AI Funding Faces a Reality Check: New 2027 Outlook Puts Outsourcing Savings to the Test
-
Jaguar Mining Provides Update on Permitting of the Onças de Pitangui Development Project, Minas Gerais, Brazil
-
Ur-Energy Announces Retirement of CFO Roger Smith, Names VP Finance Jade Walle as Successor
-
DataMEDS AI Enters Into Agreement for Commercial Supply of Six Peptides Recommended by FDA Advisory Committee
-
Aer Lingus and MTech Mobility Launch Live Ground Operations Technology Programme Across Three Irish Airports
-
InterContinental Hotels Group PLC Announces Transaction in Own Shares - November 02
-
Proven IT Announces a Partnership with Atom Cybersecurity to Deliver Specialized Cybersecurity Expertise and Enhanced Protection for Businesses
-
Nexscient Announces Expanded Customer Engagements and New Commercial Agreements in Autonomous Driving and Humanoid Robotics Data Services
-
Marijuana Rescheduling In Peril: AMA Demands FDA Scientific Standards As GAO Report Exposes Malaise
-
QNX Launches Global Developer Hackathon with $50,000 in Prizes to Accelerate Innovation in Mission-Critical Systems
-
OSR Health Board Authorizes Management to Engage with Potential Acquirer of OSRK for Reverse Takeover
-
PPX Mining Initiates Operating Permit Process for Igor Processing Plant
-
Menhaden "Miss the Target" Soundbite Leaves Out the Full Story
-
QuickMD Names Omar Manejwala, M.D. as Chief Medical Officer
Atomera Provides Fourth Quarter and Fiscal 2024 Results
LOS GATOS, CA / ACCESS Newswire / February 11, 2025 / Atomera Incorporated (NASDAQ:ATOM), a semiconductor materials and technology licensing company, today provided a corporate update and announced financial results for the fourth quarter and fiscal year ended December 31, 2024.
Recent Company Highlights
Continued progress toward commercialization at ST Microelectronics
Expanded offerings for gate-all-around products, the foundation technology of the most advanced AI devices
Newly initiated development efforts with two large customers
Management Commentary
"Recent progress with large customers has reinforced the attractiveness of MST to solve some of the most difficult problems faced by semiconductor companies, which is the key to Atomera licensing customers and bringing our technology to production," said Scott Bibaud, President and CEO. "The semiconductor industry is currently in an ideal state to adopt new technology and the performance improvements enabled by MST are compelling to fabs and foundries seeking to gain cost-effective advantages in highly competitive markets."
Financial Results
The Company incurred a net loss of ($4.7) million, or ($0.16) per basic and diluted share in the fourth quarter of 2024, compared to a net loss of ($4.6) million, or ($0.17) per basic and diluted share, for the third quarter of 2024, and a net loss of ($4.6) million, or ($0.18) per basic and diluted share, for the fourth quarter of 2023. Adjusted EBITDA (a non-GAAP financial measure) in the fourth quarter of 2024 was a loss of ($3.9) million compared to an adjusted EBITDA loss of ($3.9) million in the third quarter of 2024 and ($3.7) million in the fourth quarter of 2023.
For fiscal year 2024, revenue was $135,000, compared with $550,000 in fiscal 2023. Net loss was ($18.4) million, or ($0.68) per basic and diluted share for fiscal 2024, compared to ($19.8) million, or ($0.80) per basic and diluted share in fiscal 2023. Adjusted EBITDA for fiscal 2024 was a loss of ($15.4) million compared to an adjusted EBITDA loss of ($16.6) million in fiscal 2023.
The Company had $26.8 million in cash, cash equivalents and short-term investments as of December 31, 2024, compared to $19.5 million as of December 31, 2023.
The total number of shares outstanding was 30.1 million as of December 31, 2024.
Fourth Quarter and Fiscal Year 2024 Results Webinar
Atomera will host a live video webinar today to discuss its financial results and recent progress.
Date: Tuesday, Feb. 11, 2025
Time: 2:00 p.m. PT (5:00 p.m. ET)
Webcast: Accessible at https://ir.atomera.com
Note about Non-GAAP Financial Measures
In addition to the unaudited results presented in accordance with generally accepted accounting principles, or GAAP, in this press release, Atomera presents adjusted EBITDA, which is a non-GAAP financial measure. Adjusted EBITDA is determined by taking net loss and eliminating the impacts of interest, depreciation, amortization and stock-based compensation. Our definition of adjusted EBITDA may not be comparable to the definitions of similarly-titled measures used by other companies. We believe that this non-GAAP financial measure, viewed in addition to and not in lieu of our reported GAAP results, provides useful information to investors by providing a more focused measure of operating results. This metric is used as part of the Company's internal reporting to evaluate its operations and the performance of senior management. A table reconciling this measure to the comparable GAAP measure is available in the accompanying financial tables below.
About Atomera Incorporated
Atomera Incorporated is a semiconductor materials and technology licensing company focused on deploying its proprietary, silicon-proven technology into the semiconductor industry. Atomera has developed Mears Silicon Technology™ (MST®), which increases performance and power efficiency in semiconductor transistors. MST can be implemented using equipment already deployed in semiconductor manufacturing facilities and is complementary to other nano-scaling technologies already in the semiconductor industry roadmap. More information can be found at www.atomera.com.
Safe Harbor
This press release contains forward-looking statements concerning Atomera Incorporated, including statements regarding the prospects for the semiconductor industry generally and the ability of our MST technology to significantly improve semiconductor performance. Those forward-looking statements involve known and unknown risks, uncertainties and other factors that could cause actual results to differ materially. Among those factors are: (1) the fact that, to date, we have only recognized minimal engineering services and licensing revenues thus subjecting us to all the risks inherent in an early-stage enterprise; (2) the risk that licensees or JDA customers do not advance to royalty-based manufacturing and distribution licenses; (3) our ability to add other licensees and/or JDA customers; (4) risks related to our ability to raise sufficient capital, as and when needed, to pursue the further development, licensing and commercialization of our MST technology; (5) our ability to protect our proprietary technology, trade secrets and knowhow and (6) those other risks disclosed in the section "Risk Factors" included in our Annual Report on Form 10-K filed with the SEC on February 15, 2024. We caution readers not to place undue reliance on any forward-looking statements. We do not undertake, and specifically disclaim any obligation, to update or revise such statements to reflect new circumstances or unanticipated events as they occur.
-- Financial Tables Follow --
Atomera Incorporated
Balance Sheets
(in thousands, except per share data)
December 31, | December 31, | |||
2024 | 2023 | |||
(Unaudited) | ||||
ASSETS | ||||
Current assets: | ||||
Cash and cash equivalents | $ | 25,778 | $ | 12,591 |
Short-term investments | 995 | 6,940 | ||
Accounts receivable | 6 | - | ||
Unbilled contracts receivable | - | 550 | ||
Interest receivable | 73 | 79 | ||
Prepaid expenses and other current assets | 240 | 244 | ||
Total current assets | 27,092 | 20,404 | ||
Property and equipment, net | 59 | 100 | ||
Long-term prepaid maintenance and supplies | 91 | 91 | ||
Security deposit | 14 | 14 | ||
Operating lease right-of-use asset | 280 | 517 | ||
Financing lease right-of-use-asset | 1,588 | 2,903 | ||
Total assets | $ | 29,124 | $ | 24,029 |
LIABILITIES AND STOCKHOLDERS' EQUITY | ||||
Current liabilities: | ||||
Accounts payable | $ | 492 | $ | 618 |
Accrued expenses | 239 | 222 | ||
Accrued payroll related expenses | 1,328 | 1,382 | ||
Current operating lease liability | 260 | 264 | ||
Current financing lease liability | 1,253 | 1,328 | ||
Deferred revenue | 4 | - | ||
Total current liabilities | 3,576 | 3,814 | ||
Long-term operating lease liability | 22 | 295 | ||
Long-term financing lease liability | 449 | 1,750 | ||
Total liabilities | 4,047 | 5,859 | ||
Commitments and contingencies | - | - | ||
Stockholders' equity: | ||||
Preferred stock $0.001 par value, authorized 2,500 shares; none issued and outstanding at December 31, 2024 and December 31, 2023 | - | - | ||
Common stock: $0.001 par value, authorized 47,500 shares; 30,540 and 26,107 shares issued and outstanding as of December 31, 2024 and December 31, 2023, respectively; | 31 | 26 | ||
Additional paid-in capital | 246,565 | 221,229 | ||
Other comprehensive income | 1 | - | ||
Accumulated deficit | (221,520 | ) | (203,085 | ) |
Total stockholders' equity | 25,077 | 18,170 | ||
Total liabilities and stockholders' equity | $ | 29,124 | $ | 24,029 |
Atomera Incorporated
Statements of Operations
(in thousands, except per share data)
Three Months Ended | Year Ended | ||||||||||||||
December 31, | September 30, | December 31, | December 31, | ||||||||||||
2024 | 2024 | 2023 | 2024 | 2023 | |||||||||||
(Unaudited) | (Unaudited) | (Unaudited) | (Unaudited) | ||||||||||||
Revenue | $ | 23 | $ | 22 | $ | 550 | $ | 135 | $ | 550 | |||||
Cost of revenue | (13 | ) | (3 | ) | (28 | ) | (123 | ) | (28 | ) | |||||
Gross margin | 10 | 19 | 522 | 12 | 522 | ||||||||||
Operating expenses | |||||||||||||||
Research and development | 2,823 | 2,759 | 2,992 | 11,029 | 12,525 | ||||||||||
General and administrative | 1,811 | 1,812 | 1,875 | 7,266 | 7,075 | ||||||||||
Selling and marketing | 248 | 248 | 452 | 1,053 | 1,599 | ||||||||||
Total operating expenses | 4,882 | 4,819 | 5,319 | 19,348 | 21,199 | ||||||||||
Loss from operations | (4,872 | ) | (4,800 | ) | (4,797 | ) | (19,336 | ) | (20,677 | ) | |||||
Other income (expense) | |||||||||||||||
Interest income | 213 | 176 | 195 | 779 | 723 | ||||||||||
Accretion income | 26 | 59 | 62 | 178 | 283 | ||||||||||
Other income (expense), net | 1 | - | 3 | 73 | 75 | ||||||||||
Interest expense | (25 | ) | (30 | ) | (43 | ) | (129 | ) | (194 | ) | |||||
Total other income (expense), net | 215 | 205 | 217 | 901 | 887 | ||||||||||
Net loss | $ | (4,657 | ) | $ | (4,595 | ) | $ | (4,580 | ) | $ | (18,435 | ) | $ | (19,790 | ) |
Net loss per common share, basic and diluted | $ | (0.16 | ) | $ | (0.17 | ) | $ | (0.18 | ) | $ | (0.68 | ) | $ | (0.80 | ) |
Weighted average number of common shares outstanding, basic and diluted | 28,934 | 27,406 | 25,404 | 27,217 | 24,755 | ||||||||||
Atomera Incorporated
Reconciliation to Non-GAAP EBITDA
(Unaudited)
Three Months Ended | Year Ended | ||||||||||||||
December 31, | September 30, | December 31, | December 31, | ||||||||||||
2024 | 2024 | 2023 | 2024 | 2023 | |||||||||||
Net loss (GAAP) | $ | (4,657 | ) | $ | (4,595 | ) | $ | (4,580 | ) | $ | (18,435 | ) | $ | (19,790 | ) |
Depreciation and amortization | 12 | 12 | 17 | 54 | 77 | ||||||||||
Stock-based compensation | 949 | 907 | 1,015 | 3,867 | 4,013 | ||||||||||
Interest income | (213 | ) | (176 | ) | (195 | ) | (779 | ) | (723 | ) | |||||
Accretion income | (26 | ) | (59 | ) | (62 | ) | (178 | ) | (283 | ) | |||||
Other income, net | (1 | ) | - | (3 | ) | (73 | ) | (75 | ) | ||||||
Interest expense | 25 | 30 | 43 | 129 | 194 | ||||||||||
Net loss non-GAAP EBITDA | $ | (3,911 | ) | $ | (3,881 | ) | $ | (3,765 | ) | $ | (15,415 | ) | $ | (16,587 | ) |
Investor Contact:
Bishop IR
Mike Bishop
(415) 894-9633
[email protected]
SOURCE: Atomera, Inc
View the original press release on ACCESS Newswire
R.Lee--AT